Bank of America
RVMD icon

Bank of America’s Revolution Medicines RVMD Stock Holding History

Bank of America’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184M Buy
983,911
+369,754
+60% +$54M 0.01% 824
2026
Q1 		$59.7M Sell
614,157
-265,688
-30% -$26.8M ﹤0.01% 1477
2025
Q4 		$70.1M Buy
879,845
+125,978
+17% +$8.26M 0.01% 1327
2025
Q3 		$35.2M Buy
753,867
+177,184
+31% +$6.94M ﹤0.01% 2054
2025
Q2 		$21.2M Buy
576,683
+130,121
+29% +$5M ﹤0.01% 2504
2025
Q1 		$15.8M Buy
446,562
+45,519
+11% +$1.85M ﹤0.01% 2704
2024
Q4 		$17.5M Sell
401,043
-27,075
-6% -$1.37M ﹤0.01% 2426
2024
Q3 		$19.4M Buy
428,118
+27,551
+7% +$1.2M ﹤0.01% 2427
2024
Q2 		$15.5M Sell
400,567
-143,519
-26% -$5.36M ﹤0.01% 2496
2024
Q1 		$17.5M Buy
544,086
+298,079
+121% +$8.83M ﹤0.01% 2420
2023
Q4 		$7.06M Buy
246,007
+77,232
+46% +$1.86M ﹤0.01% 3246
2023
Q3 		$4.67M Sell
168,775
-49,706
-23% -$1.47M ﹤0.01% 3476
2023
Q2 		$5.84M Sell
218,481
-723,252
-77% -$17.7M ﹤0.01% 3247
2023
Q1 		$20.4M Buy
941,733
+500,318
+113% +$12.3M ﹤0.01% 2107
2022
Q4 		$10.5M Buy
441,415
+224,037
+103% +$4.76M ﹤0.01% 2647
2022
Q3 		$4.29M Buy
217,378
+111,920
+106% +$2.46M ﹤0.01% 3490
2022
Q2 		$2.06M Sell
105,458
-105,117
-50% -$2.05M ﹤0.01% 4278
2022
Q1 		$5.37M Buy
210,575
+178,069
+548% +$3.88M ﹤0.01% 3540
2021
Q4 		$818K Buy
32,506
+12,149
+60% +$342K ﹤0.01% 5464
2021
Q3 		$560K Sell
20,357
-8,076
-28% -$235K ﹤0.01% 5562
2021
Q2 		$902K Buy
28,433
+15,732
+124% +$549K ﹤0.01% 4993
2021
Q1 		$582K Buy
12,701
+3,442
+37% +$154K ﹤0.01% 5243
2020
Q4 		$366K Sell
9,259
-908
-9% -$35.9K ﹤0.01% 5211
2020
Q3 		$354K Buy
10,167
+3,958
+64% +$110K ﹤0.01% 4955
2020
Q2 		$196K Sell
6,209
-8,066
-57% -$254K ﹤0.01% 5260
2020
Q1 		$313K Buy
+14,275
New +$395K ﹤0.01% 4827

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bank of America's RVMD Position: Q2 2026 in Review

Bank of America increased its Revolution Medicines (RVMD) stake by 60% in Q2 2026, buying an estimated $54M and bringing the position to 983,911 shares worth $184M. The position accounts for 0.01% of the portfolio, ranked #824.

Bank of America first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bank of America held 983,911 shares of Revolution Medicines worth $184M as of Q2 2026.
  • Bank of America bought 369,754 Revolution Medicines shares in Q2 2026, an estimated $54M.
  • Revolution Medicines made up 0.01% of Bank of America's portfolio in Q2 2026, its #824 holding.
  • Bank of America first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.